# Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

> **NCT00084695** · PHASE2 · UNKNOWN · sponsor: **Milton S. Hershey Medical Center** · enrollment: 25 (estimated)

## Conditions studied

- Childhood Langerhans Cell Histiocytosis
- Fanconi Anemia
- Leukemia
- Lymphoma
- Myelodysplastic Syndromes
- Neuroblastoma
- Sarcoma
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** fludarabine phosphate
- **DRUG:** melphalan
- **DRUG:** methylprednisolone
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00084695
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-09
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2014-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00084695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00084695, "Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00084695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*